Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients


Therapy for multiple myeloma (MM) has markedly changed in the past decade with the introduction of new drugs, but it is not clear whether the improvements have been sustained. We studied 1038 patients diagnosed between 2001 and 2010, grouping patients into two 5-year periods by diagnosis, 2001–2005 and 2006–2010. The median estimated follow-up for the… (More)
DOI: 10.1038/leu.2013.313


6 Figures and Tables